Metastatic Cervical Cancer Completed Phase 2 Trials for Cadonilimab (DB16680)

Also known as: Metastatic Cervical Cancers / Cervical Cancer Metastatic

IndicationStatusPhase
DBCOND0036674 (Metastatic Cervical Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04380805A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical CancerTreatment